BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6155195)

  • 1. Efficient removal of abnormal immunoglobulin G from plasma of a multiple myeloma patient. Description of a new method for treatment of the hyperviscosity syndrome.
    Ray PK; Besa E; Idiculla A; Rhoads JE; Bassett JG; Cooper DR
    Cancer; 1980 May; 45(10):2633-8. PubMed ID: 6155195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature.
    Pruzanski W; Watt JG
    Ann Intern Med; 1972 Dec; 77(6):853-60. PubMed ID: 4644164
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperviscosity syndrome in multiple myeloma.
    Lancet; 1973 Feb; 1(7799):359-60. PubMed ID: 4121944
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome.
    Benninger GW; Kreps SI
    Am J Med; 1971 Aug; 51(2):287-93. PubMed ID: 5095532
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperviscosity in IgG myeloma: detection and treatment in community medical facilities.
    Seward CW; Osterland CK
    Tex Med; 1974 Mar; 70(3):63-5. PubMed ID: 4818033
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum viscosity and hyperviscosity syndrome in IGG multiple myeloma - the relationship of Sia test and to concentration of M component.
    Pruzanski W; Russell ML
    Am J Med Sci; 1976; 271(2):145-50. PubMed ID: 1266887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.
    Gauckler P; Leierer J; Kocher F; Feistritzer C; Willenbacher W; Gunsilius E; Wolf D; Neuwirt H; Mayer G; Kronbichler A
    J Clin Apher; 2020 Jun; 35(3):227-230. PubMed ID: 32142176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperviscosity syndrome with IgA myeloma.
    Dine ME; Guay AT; Snyder LM
    Am J Med Sci; 1972 Aug; 264(2):111-5. PubMed ID: 4653114
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperviscosity syndrome complicating immunoglobulin G myeloma-Cognisance of early plasmapheresis is crucial.
    Vivek S; Kundan M; Rajat B; Gaurav S; Manu D; Suman P; Singh V
    Semin Dial; 2023 Mar; 36(2):175-177. PubMed ID: 36541085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of IgG lambda myeloma associated with hyperviscosity syndrome. A speculative mechanism of hyperviscosity syndrome with relative low serum viscosity (author's transl)].
    Katsuki A; Shimazaki C; Osamura K; Nakanishi S; Kayawake S; Sasaki T; Murano K; Nakata T; Nishio A; Hosoda M; Haruyama H; Matsushima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1979 Jun; 20(6):658-66. PubMed ID: 112269
    [No Abstract]   [Full Text] [Related]  

  • 13. The hyperviscosity syndrome. I. In IgG myeloma. The role of protein concentration and molecular shape.
    MacKenzie MR; Fudenberg HH; O'Reilly RA
    J Clin Invest; 1970 Jan; 49(1):15-20. PubMed ID: 5409803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal immunoadsorption of myeloma IgG and autoimmune antibodies: a clinically feasible modality of treatment.
    Ray PK; Besa E; Idiculla A; Rhoads JE; Bassett JG; Cooper DR
    Clin Exp Immunol; 1980 Nov; 42(2):308-14. PubMed ID: 7008987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].
    Tsunoda S; Sasaki R; Miwa A; Sakurabayashi I; Miura Y
    Rinsho Ketsueki; 1989 Mar; 30(3):361-5. PubMed ID: 2504973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperviscosity syndrome].
    Hashimoto T
    Nihon Rinsho; 1995 Mar; 53(3):695-8. PubMed ID: 7699907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG-K-multiple myeloma with hyperviscosity syndrome--response to plasmapheresis.
    Wolf RE; Alperin JB; Ritzmann SE; Levin WC
    Arch Intern Med; 1972 Jan; 129(1):114-7. PubMed ID: 5008038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperviscosity syndrome as the initial manifestation of IgG myeloma].
    Luna G; Lite M; Abad JA
    Rev Clin Esp; 1982 Aug 15-31; 166(3-4):181-2. PubMed ID: 6815728
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of hyperviscosity in monoclonal gammopathies.
    Crawford J; Cox EB; Cohen HJ
    Am J Med; 1985 Jul; 79(1):13-22. PubMed ID: 4014299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG myeloma, Sia test, and serum hyperviscosity.
    Rubies-Prat J; Gallart MT; Frison JC; Caralps A; Schwartz S; Bacardi R
    Acta Haematol; 1974; 52(2):107-11. PubMed ID: 4214602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.